Complete Wegovy vs Mounjaro System Duration Guide
How Long Does Wegovy Stay in Your System: Semaglutide vs Tirzepatide Breakdown
When considering how long Wegovy stays in your system compared to Mounjaro, both treatments have similar elimination timeframes but work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that remains active in your system for approximately 5-7 days, which is why it's administered once weekly. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, also with a weekly dosing schedule and comparable system duration. The key difference lies in how each medication processes through your body during this time.
Understanding how long Wegovy stays in your system helps explain the dosing schedule and potential side effects timeline. Both medications reach steady-state concentrations after 4-5 weeks of regular dosing, meaning the amount entering your system balances with the amount being eliminated. This is why dose escalation occurs gradually over several months, allowing your body to adjust to each strength. The system duration also influences when side effects may occur or resolve, typically within the first few days after injection when medication levels are highest.
Wegovy vs Mounjaro Pricing: How Long-Term System Effects Impact Value
The cost of understanding how long Wegovy stays in your system becomes clearer when comparing pricing across the dose escalation journey. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) is priced at £369.99. New customers use code FIRST40 at checkout, whilst returning customers apply code DOSE25 to reach these final prices.
Mounjaro follows a different pricing structure with six dose levels (2.5mg to 15mg), reflecting its dual-receptor mechanism and how long the medication stays active in your system. The extended system duration of both treatments means weekly injections provide consistent appetite control and weight management support. Our Ultimate Stability Trio (three 2.4mg Wegovy pens) offers three months of maintenance supply for £649.99, providing convenience through fewer orders and Reliable Supply continuity. Bundle options focus on convenience rather than savings, ensuring uninterrupted treatment as you progress through the dose escalation schedule.
Clinical Evidence: How Long Wegovy System Duration Affects Results
The STEP trial programme demonstrates how long Wegovy stays effective in your system translates to clinical outcomes. In STEP 1, patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The consistent weekly dosing ensures steady medication levels that may help maintain appetite control and satiety signals throughout the treatment period.
Understanding how long Wegovy remains in your system helps explain the sustained effects seen in long-term studies. STEP 5 demonstrated that patients maintained approximately clinically studied weight loss at two years, suggesting the weekly elimination and replacement cycle provides consistent therapeutic benefit. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, indicating the system duration supports broader health improvements beyond weight management.
Wegovy Mechanism: How System Duration Enables GLP-1 Action
The question of how long Wegovy stays in your system directly relates to its mechanism as a GLP-1 receptor agonist. Semaglutide mimics the natural hormone GLP-1, which signals satiety and reduces appetite through brain appetite centres. The medication's 5-7 day system duration means these appetite-suppressing effects remain consistent between weekly injections, helping reduce food cravings and promote feelings of fullness after smaller meals. This extended action differentiates Wegovy from shorter-acting appetite medications that require multiple daily doses. The steady medication levels achieved through weekly dosing may provide more stable appetite control compared to treatments with fluctuating concentrations throughout the day.
EverydayMeds Ordering: System Duration Considerations in Assessment
Our streamlined ordering process considers how long Wegovy stays in your system when matching patients to appropriate treatments. The 3-minute online clinical assessment evaluates your medical history, current medications, and weight management goals to ensure safe prescribing. Our prescribers review applications within three working days (or 24 hours with express service), considering how the medication's system duration might interact with your existing treatments or medical conditions. Once approved, next-day delivery ensures rapid treatment initiation through our temperature-controlled cold-chain logistics. The assessment specifically evaluates whether the weekly dosing schedule and system duration align with your lifestyle and treatment preferences, comparing Wegovy and Mounjaro options where clinically appropriate.
Storage and Practical Considerations: How System Duration Affects Usage
Understanding how long Wegovy stays in your system connects to practical storage considerations that differentiate it from Mounjaro. Wegovy pens remain stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. This storage advantage proves valuable for travel or situations where refrigeration isn't immediately available, complementing the weekly dosing schedule. The FlexTouch pen design ensures accurate dose delivery throughout the temperature stability period. Dose escalation follows a mandatory schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) over 16 weeks, with each strength requiring separate pens due to the fixed-dose delivery system.
Wegovy vs Mounjaro System Comparison: Elimination Timeline Impact
The specific question of how long Wegovy stays in your system versus Mounjaro reveals important practical differences. Both medications require approximately 5-7 days for elimination, but Mounjaro's dual GLP-1/GIP mechanism may produce different side effect profiles during this elimination period. Wegovy's single-receptor targeting often results in more predictable system effects as medication levels decline between doses. The similar elimination timeframes mean both treatments require consistent weekly administration for optimal effectiveness.
When comparing how long each medication stays active in your system, consider that Mounjaro's higher maximum dose (15mg vs Wegovy's 2.4mg) may result in different elimination experiences at maintenance levels. Both treatments are available through EverydayMeds with expert prescriber guidance to help determine which option best suits your individual system tolerance and treatment goals. The comparable system duration means switching between treatments requires careful medical supervision and potentially overlapping elimination periods.
Expert Guidance: Optimising Treatment Based on System Duration
Our clinical team at EverydayMeds understands how long Wegovy stays in your system impacts treatment success and can guide you through both Wegovy and Mounjaro options. As a GPhC-registered pharmacy (#9012878), we ensure all prescribing considers the medication's system duration alongside your individual medical profile. The weekly elimination cycle requires consistent adherence to maintain therapeutic levels, and our prescribers provide detailed guidance on timing, storage, and what to expect as medication processes through your system. Whether choosing Wegovy's established GLP-1 approach or Mounjaro's dual-receptor mechanism, understanding system duration helps set realistic expectations for onset, duration, and resolution of both therapeutic effects and potential side effects. Visit https://everydaymeds.co.uk/collections/weight-loss to start your clinical assessment and discover which treatment aligns with your needs, with both options available for next-day delivery once approved.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
